David Einhorn's COYA Position Overview
David Einhorn (via Dme Capital Management, Lp) currently holds 2.34 M shares of Coya Therapeutics, Inc. (COYA) worth $13.66 M, representing 0.35% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 15 quarters.
Based on 13F filings, David Einhorn has maintained a strategic position in COYA, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 805,959 shares.
Analysis based on 13F filings available since 2013 Q2
David Einhorn's Coya Therapeutics (COYA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Coya Therapeutics (COYA) Trades by David Einhorn
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +309,600 | Add 15.28% | 2.34 M | $3.94 |
| Q4 2025 | +379,500 | Add 23.05% | 2.03 M | $5.80 |
| Q4 2024 | +372,414 | Add 29.23% | 1.65 M | $5.73 |
| Q1 2024 | +1.27 M | Add 0.00% | 1.27 M | $9.92 |
| Q4 2023 | +805,959 | Add 172.19% | 1.27 M | $7.41 |
| Q3 2023 | +75,420 | Add 19.21% | 468,067 | $3.84 |
| Q1 2023 | +203 | Add 0.05% | 392,647 | $3.97 |
| Q4 2022 | +392,444 | New Buy | 392,444 | $4.74 |
David Einhorn's Coya Therapeutics Investment FAQs
David Einhorn first purchased Coya Therapeutics, Inc. (COYA) in Q4 2022, acquiring 392,444 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
David Einhorn has held Coya Therapeutics, Inc. (COYA) for 15 quarters since Q4 2022.
David Einhorn's largest addition to Coya Therapeutics, Inc. (COYA) was in Q1 2024, adding 1,274,026 shares worth $12.64 M.
According to the latest 13F filing for Q2 2026, David Einhorn's firm, Dme Capital Management, Lp, owns 2,335,540 shares of Coya Therapeutics, Inc. (COYA), valued at approximately $13.66 M.
As of the Q2 2026 filing, Coya Therapeutics, Inc. (COYA) represents approximately 0.35% of David Einhorn's publicly disclosed stock portfolio, making it one of their key holdings.
David Einhorn's peak holding in Coya Therapeutics, Inc. (COYA) was 2,335,540 shares, as reported at the end of Q1 2026.